Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens.
FK506
FKBP12
TOR
antifungal
calcineurin
fungi
rapamycin
Journal
Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
07
2020
accepted:
22
09
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
Over the past few decades advances in modern medicine have resulted in a global increase in the prevalence of fungal infections. Particularly people undergoing organ transplants or cancer treatments with a compromised immune system are at an elevated risk for lethal fungal infections such as invasive candidiasis, aspergillosis, cryptococcosis, etc. The emergence of drug resistance in fungal pathogens poses a serious threat to mankind and it is critical to identify new targets for the development of antifungals. Calcineurin and TOR proteins are conserved across eukaryotes including pathogenic fungi. Two small molecules FK506 and rapamycin bind to FKBP12 immunophilin and the resulting complexes (FK506-FKBP12 and rapamycin-FKBP12) target calcineurin and TOR, respectively in both humans and fungi. However, due to their immunosuppressive nature these drugs in the current form cannot be used as an antifungal. To overcome this, it is important to identify key differences between human and fungal FKBP12, calcineurin, and TOR proteins which will facilitate the development of new small molecules with higher affinity toward fungal components. The current review highlights FK506/rapamycin-FKBP12 interactions with calcineurin/TOR kinase in human and fungi, and development of non-immunosuppressive analogs of FK506, rapamycin, and novel small molecules in inhibition of fungal calcineurin and TOR kinase.
Identifiants
pubmed: 33195437
doi: 10.3389/fmolb.2020.588913
pmc: PMC7596385
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
588913Subventions
Organisme : NIGMS NIH HHS
ID : R25 GM060655
Pays : United States
Informations de copyright
Copyright © 2020 Vellanki, Garcia and Lee.
Références
Virulence. 2018 Dec 31;9(1):707-720
pubmed: 29436903
Front Microbiol. 2017 Jan 12;7:2173
pubmed: 28127295
Genetics. 2011 Dec;189(4):1177-201
pubmed: 22174183
Rev Neurol (Paris). 2006 Feb;162(2):233-7
pubmed: 16518265
Clin Chest Med. 2017 Sep;38(3):465-477
pubmed: 28797489
Fungal Biol Rev. 2014 Oct;28(2-3):56-69
pubmed: 25383089
Mol Microbiol. 2003 May;48(4):959-76
pubmed: 12753189
Physiol Rev. 2000 Oct;80(4):1483-521
pubmed: 11015619
Antimicrob Agents Chemother. 1997 Jan;41(1):156-61
pubmed: 8980772
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2465-2471
pubmed: 28412204
Clin Infect Dis. 2003 Jul 15;37(2):221-9
pubmed: 12856215
EMBO J. 1997 May 15;16(10):2576-89
pubmed: 9184205
Kidney Int. 2001 Jan;59(1):3-16
pubmed: 11135052
F1000 Med Rep. 2011;3:14
pubmed: 21876720
Proteomics. 2015 Jul;15(13):2230-43
pubmed: 25728394
Emerg Infect Dis. 2009 Jul;15(7):1068-76
pubmed: 19624922
Curr Protoc Microbiol. 2018 May;49(1):e53
pubmed: 30040216
Sci Rep. 2017 Nov 21;7(1):15898
pubmed: 29162893
Eukaryot Cell. 2008 Jul;7(7):1085-97
pubmed: 18456861
J Antibiot (Tokyo). 1975 Oct;28(10):727-32
pubmed: 1102509
Can J Physiol Pharmacol. 1977 Feb;55(1):48-51
pubmed: 843990
Curr Fungal Infect Rep. 2019 Sep;13(3):86-98
pubmed: 31555394
Eukaryot Cell. 2003 Jun;2(3):422-30
pubmed: 12796287
Infect Immun. 2005 Sep;73(9):5767-74
pubmed: 16113294
J Med Microbiol. 2006 Jul;55(Pt 7):809-818
pubmed: 16772406
Biotechnol Adv. 2019 Nov 1;37(6):107352
pubmed: 30797093
PLoS One. 2015 Sep 14;10(9):e0137869
pubmed: 26366742
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
PLoS One. 2020 Feb 20;15(2):e0224776
pubmed: 32078630
Med Mycol. 2013 Apr;51(3):261-9
pubmed: 22989195
Clin Infect Dis. 2000 Apr;30(4):710-8
pubmed: 10770733
Nat Rev Drug Discov. 2018 Nov 28;17(12):864
pubmed: 30482965
Curr Opin Microbiol. 2010 Aug;13(4):409-15
pubmed: 20627805
Nat Rev Microbiol. 2005 Oct;3(10):753-64
pubmed: 16132036
Mol Cell Biol. 1993 Aug;13(8):5010-9
pubmed: 7687745
J Nat Prod. 2019 Aug 23;82(8):2078-2086
pubmed: 31321978
AIDS. 2001 Nov 23;15(17):2344-5
pubmed: 11698718
Curr Opin Pharmacol. 2013 Oct;13(5):726-30
pubmed: 24011516
Mol Microbiol. 2015 Sep;97(5):844-65
pubmed: 26010100
Antimicrob Agents Chemother. 2018 Oct 24;62(11):
pubmed: 30181374
Antimicrob Agents Chemother. 2004 May;48(5):1664-9
pubmed: 15105118
Antimicrob Agents Chemother. 2016 May 23;60(6):3813-6
pubmed: 26976874
Biochem Biophys Res Commun. 2020 May 21;526(1):48-54
pubmed: 32192767
Infect Dis Clin North Am. 2010 Jun;24(2):439-59
pubmed: 20466278
Clin Infect Dis. 2008 Feb 1;46(3):327-60
pubmed: 18177225
J Biol Chem. 2003 Jun 6;278(23):20457-60
pubmed: 12676950
Biomol NMR Assign. 2019 Apr;13(1):207-212
pubmed: 30707421
mBio. 2016 Apr 26;7(2):e00492-16
pubmed: 27118592
AIDS. 2006 Nov 14;20(17):2183-91
pubmed: 17086058
mBio. 2020 Jan 28;11(1):
pubmed: 31992620
J Nat Prod. 2013 Jun 28;76(6):1091-8
pubmed: 23706030
Nat Chem. 2019 Mar;11(3):254-263
pubmed: 30532015
J Biol Chem. 1993 Apr 15;268(11):7607-9
pubmed: 7681823
J Exp Med. 1992 Sep 1;176(3):751-60
pubmed: 1380976
Am J Transplant. 2006;6(5 Pt 2):1111-31
pubmed: 16613591
Immunol Today. 1992 Apr;13(4):136-42
pubmed: 1374612
J Biol Chem. 2018 Jan 12;293(2):412-432
pubmed: 29158264
PLoS Pathog. 2013;9(9):e1003625
pubmed: 24039585
FEMS Yeast Res. 2015 Nov;15(7):
pubmed: 26347504
Antimicrob Agents Chemother. 2001 Nov;45(11):3162-70
pubmed: 11600372
J Infect Dis. 1997 Jan;175(1):222-5
pubmed: 8985226
J Antimicrob Chemother. 2003 Feb;51(2):313-6
pubmed: 12562696
J Ind Microbiol Biotechnol. 2016 Mar;43(2-3):389-400
pubmed: 26342319
Can J Infect Dis Med Microbiol. 2016;2016:5930489
pubmed: 28058052
Antimicrob Agents Chemother. 2000 Sep;44(9):2296-303
pubmed: 10952571
PLoS One. 2008 Aug 06;3(8):e2870
pubmed: 18682846
Genetics. 2019 Aug;212(4):1241-1258
pubmed: 31175227
Drugs. 2007;67(11):1567-601
pubmed: 17661528
Nat Rev Microbiol. 2007 Jun;5(6):418-30
pubmed: 17505522
Ann Intern Med. 1990 Aug 1;113(3):183-7
pubmed: 2197908
Int J Antimicrob Agents. 2017 Nov;50(5):617-621
pubmed: 28802855
J Clin Microbiol. 2004 Oct;42(10):4419-31
pubmed: 15472288
Antimicrob Agents Chemother. 2015 Dec;59(12):7197-204
pubmed: 26324276
Genes Dev. 1999 Dec 15;13(24):3271-9
pubmed: 10617575
J Antibiot (Tokyo). 1987 Sep;40(9):1249-55
pubmed: 2445721
Expert Opin Drug Discov. 2017 Sep;12(9):909-923
pubmed: 28758515
Virulence. 2017 Feb 17;8(2):150-158
pubmed: 27268130
Mol Cell Biol. 1999 Jun;19(6):4101-12
pubmed: 10330150
Immunol Today. 1989 Jan;10(1):6-9
pubmed: 2473767
Nat Chem Biol. 2016 Oct;12(10):867-75
pubmed: 27571477
Eukaryot Cell. 2012 Mar;11(3):270-81
pubmed: 22210828
Front Microbiol. 2019 Nov 21;10:2573
pubmed: 31824443
Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34
pubmed: 22247442
Science. 1991 Aug 23;253(5022):905-9
pubmed: 1715094
Infect Drug Resist. 2017 Aug 29;10:249-259
pubmed: 28919789
Science. 2012 Mar 30;335(6076):1638-43
pubmed: 22461615
Cell. 1991 Aug 23;66(4):807-15
pubmed: 1715244
Eukaryot Cell. 2006 Jul;5(7):1091-103
pubmed: 16835453
Bioorg Med Chem. 2017 Aug 1;25(15):4145-4152
pubmed: 28625715
Sci Rep. 2018 Aug 1;8(1):11559
pubmed: 30068935
Nat Commun. 2019 Sep 19;10(1):4275
pubmed: 31537789
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:1-10
pubmed: 14748798
Antimicrob Agents Chemother. 2010 Apr;54(4):1555-63
pubmed: 20124000
Emerg Infect Dis. 2020 Apr;26(4):804-806
pubmed: 32186508
Infect Immun. 2005 Apr;73(4):2012-9
pubmed: 15784542